Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: A meta-analysis of six prospective, randomized, comparative studies-Reference-Cited by-同舟云学术

Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: A meta-analysis of six prospective, randomized, comparative studies

Published:2004-01 Issue:1 Volume:26 Page:92-97
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Moyle Graeme,Sawyer Will,Law Matthew,Amin Janaki,Hill Andrew

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: Results from the Multistate Adult and Adolescent Spectrum of HIV Disease Surveillance Project;Sullivan;Blood,1998

2. Symptomatology of anemia;Ludwig;Semin Oncol.,2001

3. Fatigue in cancer and HIV/AIDS;Groopman;Oncology (Hunting),1998

4. Fatigue: A main component of anemia symptomatology;Sobrero;Semin Oncol.,2001

5. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's interagency HIV study;Levine;J Acquir Immune Defic Syndr.,2001

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of dolutegravir on ferritin, iron, and C-reactive protein among people living with HIV and co-infections;Southern African Journal of HIV Medicine;2024-04-30

2. The hematologic profile of Filipino HIV-infected individuals and its association with CD4 counts;Hematology, Transfusion and Cell Therapy;2021-01

3. Anemia, Iron Status, and HIV: A Systematic Review of the Evidence;Advances in Nutrition;2020-05-08

4. Prevalence and associated factors of anemia among adult human immune deficiency virus positive patients on anti-retroviral therapy at Debre tabor Hospital, Northwest Ethiopia;BMC Research Notes;2019-03-25

5. A comparison of mean corpuscular volume (MCV) between thalassemia-carrier and non-thalassemia-carrier pregnant women receiving highly active antiretroviral therapy (HAART);Taiwanese Journal of Obstetrics and Gynecology;2017-12